Re: Final Summary as I see it

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

PVLee

Rank: Mail Room [?]

Points: 183 [?]

Votes: 1 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Final Summary as I see it

in response to

Final Summary as I see it

PVLee

posted on Dec 14, 2015 03:35PM

Apologies again...I meant to say RVX shareholders post 2013. I proofread it a few times and still goofed. No wonder there is confusion!! PVLee

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply